Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
American Shared Hospital Services (AMS)
USD1.43
+0.04 (+2.88%)
US AMEX Healthcare Medical - Care Facilities
Address
601 Montgomery Street 94111-2619
San Francisco, CA, US
San Francisco, CA, US
CEO
Gary Delanois
Website
ashs.com
IPO
1984-07-03
CIK 744825 ISIN US0295951059
Description
American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditions such as malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia. They also facilitate financing for Leksell Gamma Knife units. Additionally, the firm operates proton beam radiation therapy centers in Orlando, Florida, and Long Beach, California. Customers further benefit from comprehensive support encompassing planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, their portfolio included 115 active Gamma Knife units across the United States, complemented by two units in South America (Lima, Peru, and Guayaquil, Ecuador), and one proton beam radiation therapy system. Established in 1980, American Shared Hospital Services maintains its headquarters in San Francisco, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.43
+0.04 (+2.88%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
263.9K
Beta
0.31
Float Shares
3.91M
Free Float %
59.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.95% | -22.93% | +22.48% | -29.78% | -28.18% | -25.12% | -46.98% | -43.47% | -35.51% | -18.88% | -72.52% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.43
DCF (Levered)
3.10
+116.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.28
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-0.9% Q1'26: +15.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-169.7% Q1'26: +3.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-9.4% Q1'26: +29.8% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-5.9% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-3.5% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-1.3% ★ Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×5.56× Q1'26: -1.68× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
21.33M
est: 20.81M (+2.5%)
|
28.34M
est: 26.97M (+5.1%)
|
28.08M
est: 29.13M (-3.6%)
|
29.73M
29.73M – 29.73M
+2.1% YoY
|
| EBITDA |
6.97M
est: 5.76M (+21.0%)
|
8.91M
est: 8.68M (+2.7%)
|
4.07M
est: 9.37M (-56.6%)
|
9.57M
9.57M – 9.57M
+2.1% YoY
|
| EBIT |
1.81M
est: -105.7K (+1,810.2%)
|
2.74M
est: 2.09M (+31.2%)
|
-1.65M
est: 2.25M (-173.1%)
|
2.30M
2.30M – 2.30M
+2.1% YoY
|
| Net Income |
610.0K
est: 335.2K (+82.0%)
|
2.19M
est: 3.51M (-37.7%)
|
-1.55M
est: -793.9K (-95.6%)
|
198.5K
198.5K – 198.5K
+125.0% YoY
|
| SGA |
7.02M
est: 5.69M (+23.5%)
|
7.41M
est: 7.34M (+0.9%)
|
7.08M
est: 7.93M (-10.7%)
|
8.09M
8.09M – 8.09M
+2.1% YoY
|
| EPS |
0.10
est: 0.05 (+91.8%)
|
0.34
est: 0.53 (-35.8%)
|
-0.23
est: -0.12 (-91.7%)
|
0.03
0.03 – 0.03
+125.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.18M
OE per share TTM
-0.19
Owner's Yield
-11.09%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
144.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
6
Total invested
714.2K
Insider transactions (90d)
0
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ernest A. Bates, M.D. | 803.6K | 17.50% | 803.6K | — | 803.6K | 10.00 | IN | United States | 2011-07-15 | ↗ |
| 2 | John F. Ruffle | 550.7K | 10.10% | 550.7K | — | 550.7K | — | IN | United States | 2016-01-20 | ↗ |
| 3 | Raymond C. Stachowiak | 497.8K | 9.39% | 497.8K | — | 497.8K | — | IN | United States of America | 2014-06-17 | ↗ |
| 4 | Anita G. Zucker, as Trustee of The Article 6 Marital Trust under the First Amended and Restated Jerr | 331.2K | 5.20% | — | 331.2K | — | 10.00 | IN | USA | 2024-11-20 | ↗ |
| 5 | TIGH II, LLC | 331.2K | 5.20% | — | 331.2K | — | 10.00 | OO | Delaware | 2024-11-20 | ↗ |
| 6 | AL FRANK ASSET MANAGEMENT, INC. 95-4074555 | 298.2K | 5.94% | 223.5K | — | 298.2K | — | IA | CALIFORNIA, USA | 2008-02-14 | ↗ |
| 7 | Banque Carnegie Luxembourg S.A. | 287.3K | 5.70% | — | — | — | 287.3K | BK, IA, HC | : | 2006-02-21 | ↗ |
| 8 | Carnegie Fund Management Company S.A. | 287.3K | 5.70% | — | — | — | 287.3K | IV | : | 2006-02-21 | ↗ |
| 9 | Carnegie Investment Bank AB | 287.3K | 5.70% | — | — | — | 287.3K | BK, IA, HC | : | 2006-02-21 | ↗ |
| 10 | D Carnegie & Co. AB | 287.3K | 5.70% | — | — | — | 287.3K | HC | : | 2006-02-21 | ↗ |
| 11 | Stanley S. Trotman, JR | 268.5K | 5.80% | 268.5K | — | 268.5K | 10.00 | IN | United States | 2013-05-24 | ↗ |
| 12 | (. | 230.0K | 4.29% | 230.0K | — | 230.0K | — | IA | Delaware | 2015-02-05 | ↗ |
| 13 | Roark, Rearden, & Hamot Capital Management LLC (10-0000708) | 228.6K | 6.30% | 228.6K | — | 228.6K | — | CO | Massachusetts | 2002-05-13 | ↗ |
| 14 | American International Group, Inc. | — | 0.00% | — | — | — | — | HC | Incorporated under the laws of the State of Delaware | 1999-04-07 | ↗ |
| 15 | Anchor National Life Insurance Company | — | 0.00% | — | — | — | — | IC | Organized under the laws of the State of Arizona | 1999-04-07 | ↗ |
| 16 | SunAmerica Inc. | — | 0.00% | — | — | — | — | OO | Organized under the laws of the State of Delaware | 1999-04-07 | ↗ |
| 17 | SunAmerica Life Insurance Company | — | 0.00% | — | — | — | — | IC | Incorporated under the laws of the State of Arizona | 1999-04-07 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
6
-11 vs prev Q
New positions
4
Closed positions
15
Increased
4
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | DIMENSIONAL FUND ADVISORS LP | 206.4K -3.5K (-1.7%) | 435.5K -152.4K (-25.9%) | 3.14% -0.054 pp | 0.00% +0.000 pp | USD2.56 -17.6% | 51 qtrs — |
| 2 | VANGUARD GROUP INC | 181.1K +— (+0.0%) | 382.2K -125.0K (-24.6%) | 2.75% +0.000 pp | 0.00% +0.000 pp | USD2.83 -25.4% | 33 qtrs — |
| 3 | CI PRIVATE WEALTH, LLC | 160.6K +— (+0.0%) | 338.8K -110.8K (-24.6%) | 2.44% +0.000 pp | 0.00% 0.000 pp | USD2.93 -28.0% | 13 qtrs — |
| 4 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 94.1K -2.6K (-2.7%) | 198.6K -72.1K (-26.6%) | 1.43% -0.039 pp | 0.00% -0.002 pp | USD2.69 -21.6% | 34 qtrs — |
| 5 | DRW SECURITIES, LLC | 50.5K +50.5K (+100.0%) | 106.5K +106.5K (+100.0%) | 0.77% +0.767 pp | 0.00% +0.003 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 49.4K -400.0 (-0.8%) | 104.2K -35.2K (-25.2%) | 0.75% -0.006 pp | 0.00% +0.000 pp | USD2.88 -26.7% | 21 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 32.7K +— (+0.0%) | 69.0K -22.6K (-24.6%) | 0.50% +0.000 pp | 0.00% +0.000 pp | USD2.74 -23.0% | 10 qtrs — |
| 8 | JAMES INVESTMENT RESEARCH INC | 29.7K +— (+0.0%) | 62.7K -20.5K (-24.6%) | 0.45% +0.000 pp | 0.01% -0.002 pp | USD3.10 -31.9% | 37 qtrs — |
| 9 | NEWEDGE ADVISORS, LLC | 29.7K +— (+0.0%) | 62.7K -20.5K (-24.6%) | 0.45% +0.000 pp | 0.00% 0.000 pp | USD2.62 -19.5% | 26 qtrs — |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 27.4K +27.4K (+100.0%) | 57.8K +57.8K (+100.0%) | 0.42% +0.416 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 11 | STATE STREET CORP | 12.1K +— (+0.0%) | 25.5K -8.4K (-24.6%) | 0.18% +0.000 pp | 0.00% +0.000 pp | USD3.19 -33.9% | 5 qtrs — |
| 12 | EMPOWERED FUNDS, LLC | 11.9K +— (+0.0%) | 25.2K -8.2K (-24.6%) | 0.18% +0.000 pp | 0.00% 0.000 pp | USD2.96 -28.7% | 8 qtrs — |
| 13 | MORGAN STANLEY | 6.3K -502.0 (-7.4%) | 13.3K -5.8K (-30.2%) | 0.10% -0.008 pp | 0.00% +0.000 pp | USD2.74 -23.0% | 20 qtrs — |
| 14 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.9K +283.0 (+17.1%) | 4.1K -545.0 (-11.8%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD2.66 -20.7% | 12 qtrs — |
| 15 | CITIGROUP INC | 142.00 +142.0 (+100.0%) | 300.00 +300.0 (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 16 | JONES FINANCIAL COMPANIES LLLP | 100.00 +— (+0.0%) | 211.00 -79.0 (-27.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.80 -24.6% | 2 qtrs — |
| 17 | BANK OF AMERICA CORP /DE/ | 60.00 -5.0 (-7.7%) | 126.00 -56.0 (-30.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.30 -8.3% | 52 qtrs — |
| 18 | FARTHER FINANCE ADVISORS, LLC | — -502.0 (-100.0%) | — -1.4K (-100.0%) | 0.00% -0.008 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 19 | BARCLAYS PLC | — -20.0 (-100.0%) | — -56.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 20 | UBS GROUP AG | — -50.0 (-100.0%) | — -140.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 21 | JPMORGAN CHASE & CO | — -7.0 (-100.0%) | — -20.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 10 qtrs SOLD |
| 22 | ADVISOR GROUP HOLDINGS, INC. | — -300.0 (-100.0%) | — -840.0 (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 23 | ACADIAN ASSET MANAGEMENT LLC | — -6.2K (-100.0%) | — -17.0K (-100.0%) | 0.00% -0.094 pp | 0.00% +0.000 pp | USD— | 23 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 26 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | GMO International Quality ETF QLTI | 3.41% | 9.65M | 0.60% |
| 2 | John Hancock Investments - Multifactor Developed International ETF JHMD | 0.24% | 2.25M | 0.43% |
| 3 | State Street SPDR Portfolio Europe ETF SPEU | 0.15% | 1.07M | 0.07% |
| 4 | WisdomTree International Efficient Core Fund NTSI | 0.13% | 631.1K | 0.26% |
| 5 | State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF EFAX | 0.13% | 641.5K | 0.20% |
| 6 | Schwab International Equity ETF SCHF | 0.08% | 56.29M | 0.03% |
| 7 | State Street SPDR Portfolio Developed World ex-US ETF SPDW | 0.08% | 31.02M | 0.03% |
| 8 | State Street SPDR MSCI ACWI ex-US ETF CWI | 0.06% | 1.58M | 0.30% |
| 9 | Schwab Fundamental International Large Company Index ETF FNDF | 0.04% | 8.70M | 0.25% |
| 10 | State Street SPDR MSCI ACWI Climate Paris Aligned ETF NZAC | 0.03% | 61.1K | 0.12% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
5.6K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+5,613
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 100,000 | 0.00 | — | 774,678 | D | ↗ |
| 2025-06-26 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 110,000 | 0.00 | — | 664,678 | D | ↗ |
| 2025-04-30 | Tagawa Craig Kenji | Officer | A-Award | A | Common Stock, No Par Value | 5,613 | 0.00 | — | 35,501 | D | ↗ |
| 2024-12-19 | Frech Raymond Scott | Officer | A-Award | A | Common Stock, No Par Value | 50,000 | 0.00 | — | 50,000 | D | ↗ |
| 2024-10-14 | Delanois Gary | Officer | A-Award | A | Common Stock, No Par Value | 120,000 | 0.00 | — | 120,000 | D | ↗ |
| 2024-03-22 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 120,000 | 0.00 | — | 554,678 | — | ↗ |
| 2023-04-17 | HIATT ROBERT L | Officer | A-Award | A | Stock Options (Right to Buy) | 20,000 | 2.78 | 55.6K | 20,000 | — | ↗ |
| 2023-03-28 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 120,000 | 0.00 | — | 536,178 | — | ↗ |
| 2023-03-28 | Gaccione Peter M | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 2.93 | 146.5K | 50,000 | — | ↗ |
| 2023-03-07 | Tagawa Craig Kenji | Officer | A-Award | A | Common Stock | 10,827 | 0.00 | — | 29,888 | — | ↗ |
| 2022-05-31 | Stachowiak Raymond C | Director / Officer / 10% Owner | M-Exempt | A | Common Stock, No Par Value | 2,000 | 2.70 | 5.4K | 416,178 | — | ↗ |
| 2022-04-01 | Tagawa Craig Kenji | Officer | A-Award | A | Common Stock | 5,529 | 0.00 | — | 19,061 | — | ↗ |
| 2022-04-01 | Bates Ernest Robert | Officer | A-Award | A | Common Stock, No Par Value | 801 | 0.00 | — | 26,544 | — | ↗ |
| 2022-01-03 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 120,000 | 0.00 | — | 414,178 | — | ↗ |
| 2021-12-28 | Wilson Vicki L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-28 | Miles Kathleen | Director | A-Award | A | Common Stock, no par value | 3,000 | 0.00 | — | 3,000 | — | ↗ |
| 2021-07-01 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 60,000 | 2.94 | 176.4K | 294,178 | — | ↗ |
| 2021-06-25 | Ozyurek Saim Mert | Director | A-Award | A | Common Stock, No Par Value | 1,000 | 0.00 | — | 64,052 | — | ↗ |
| 2021-06-25 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 1,000 | 0.00 | — | 38,373 | — | ↗ |
| 2021-06-25 | Larson David | Director | A-Award | A | Common Stock, No Par Value | 1,000 | 0.00 | — | 89,816 | — | ↗ |
| 2021-06-25 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock, No Par Value | 1,000 | 0.00 | — | 49,664 | — | ↗ |
| 2021-06-04 | Larson David | Director | M-Exempt | D | Stock Options (right to buy) | 7,500 | 2.82 | 21.2K | 0 | — | ↗ |
| 2021-06-03 | Stachowiak Raymond C | Director / Officer / 10% Owner | M-Exempt | D | OPTION TO ACQUIRE | 2,000 | 2.43 | 4.9K | 0 | — | ↗ |
| 2021-06-03 | Ozyurek Saim Mert | Director | M-Exempt | D | STOCK OPTION (RIGHT TO BUY) | 2,000 | 2.43 | 4.9K | 0 | — | ↗ |
| 2021-02-01 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 60,000 | 2.55 | 153.0K | 238,061 | — | ↗ |
| 2021-01-04 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 11,521 | 2.17 | 25.0K | 37,373 | — | ↗ |
| 2021-01-04 | Larson David | Director | A-Award | A | Common Stock, No Par Value | 11,521 | 2.17 | 25.0K | 86,437 | — | ↗ |
| 2021-01-04 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock, No Par Value | 11,521 | 2.17 | 25.0K | 48,664 | — | ↗ |
| 2020-12-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 178,061 | — | ↗ |
| 2020-11-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 168,061 | — | ↗ |
| 2020-10-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 158,061 | — | ↗ |
| 2020-09-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 148,061 | — | ↗ |
| 2020-08-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 138,061 | — | ↗ |
| 2020-07-02 | Bates Ernest Robert | Officer | A-Award | A | Common Stock, No Par Value | 10,000 | 0.00 | — | 26,829 | — | ↗ |
| 2020-06-26 | Ozyurek Saim Mert | Director | A-Award | A | COMMON SHARE | 2,000 | 1.88 | 3.8K | 2,000 | — | ↗ |
| 2020-06-26 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 25,852 | — | ↗ |
| 2020-06-26 | Larson David | Director | A-Award | A | COMMON SHARE | 2,000 | 1.88 | 3.8K | 2,000 | — | ↗ |
| 2020-06-26 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 37,143 | — | ↗ |
| 2020-05-04 | Stachowiak Raymond C | Director / Officer / 10% Owner | D-Return | D | Common stock | 5,883 | 0.00 | — | 232,178 | — | ↗ |
| 2020-01-02 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | COMMON SHARE | 7,844 | 0.00 | — | 77,561 | — | ↗ |
| 2020-01-02 | Lawrence Sandra AJ | Director | A-Award | A | COMMON SHARE | 7,844 | 0.00 | — | 25,352 | — | ↗ |
| 2020-01-02 | Larson David | Director | A-Award | A | COMMON SHARE | 7,844 | 0.00 | — | 74,416 | — | ↗ |
| 2020-01-02 | Kelly Daniel G Jr | Director | A-Award | A | COMMON SHARE | 7,844 | 0.00 | — | 36,643 | — | ↗ |
| 2019-06-21 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 2,000 | 3.03 | 6.1K | 2,000 | — | ↗ |
| 2019-06-21 | Ozyurek Saim Mert | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 3.03 | 6.1K | 2,000 | — | ↗ |
| 2019-06-21 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 17,508 | — | ↗ |
| 2019-06-21 | Larson David | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 3.03 | 6.1K | 2,000 | — | ↗ |
| 2019-06-21 | Kelly Daniel G Jr | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 3.03 | 6.1K | 2,000 | — | ↗ |
| 2019-06-18 | TROTMAN STANLEY S JR | Director | M-Exempt | A | Common Stock, No Par Value | 2,000 | 2.16 | 4.3K | 81,847 | — | ↗ |
| 2019-05-15 | TROTMAN STANLEY S JR | Director | S-Sale | D | Common Stock, No Par Value | 160,559 | 2.73 | 438.3K | 79,847 | — | ↗ |
| 2019-05-15 | Stachowiak Raymond C | Director / 10% Owner | P-Purchase | A | Common Stock, No Par Value | 160,559 | 2.73 | 438.3K | 760,559 | — | ↗ |
| 2019-01-02 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 8,164 | 0.00 | — | 69,717 | — | ↗ |
| 2019-01-02 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 8,164 | 0.00 | — | 17,008 | — | ↗ |
| 2019-01-02 | Larson David | Director | A-Award | A | Common Stock, No Par Value | 8,164 | 0.00 | — | 66,072 | — | ↗ |
| 2019-01-02 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock, No Par Value | 8,164 | 0.00 | — | 28,299 | — | ↗ |
| 2018-06-18 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 1,400 | 2.77 | 3.9K | 64,391 | — | ↗ |
| 2018-06-14 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 5 | 2.70 | 13.50 | 71,291 | — | ↗ |
| 2018-06-14 | TROTMAN STANLEY S JR | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-14 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-14 | RUFFLE JOHN F | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-14 | Ozyurek Saim Mert | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 240,406 | — | ↗ |
| 2018-06-14 | Lawrence Sandra AJ | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-14 | Larson David | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-14 | Kelly Daniel G Jr | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.68 | 5.4K | 2,000 | — | ↗ |
| 2018-06-07 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 2,966 | 2.66 | 7.9K | 68,296 | — | ↗ |
| 2018-06-06 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 34 | 2.75 | 93.50 | 71,262 | — | ↗ |
| 2018-06-05 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 5,000 | 2.75 | 13.8K | 71,296 | — | ↗ |
| 2018-01-02 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 7,844 | 0.00 | — | 61,553 | — | ↗ |
| 2018-01-02 | Lawrence Sandra AJ | Director | A-Award | A | Common Stock, No Par Value | 7,844 | 0.00 | — | 8,344 | — | ↗ |
| 2018-01-02 | Larson David | Director | A-Award | A | COMMON STOCK | 7,844 | 0.00 | — | 66,508 | — | ↗ |
| 2018-01-02 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock | 7,844 | 0.00 | — | 19,635 | — | ↗ |
| 2017-09-07 | Lawrence Sandra AJ | Director | — | D | Common Stock, No Par Value | 0 | 0.00 | — | 500 | — | ↗ |
| 2017-06-27 | TROTMAN STANLEY S JR | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 239,906 | — | ↗ |
| 2017-06-27 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 53,709 | — | ↗ |
| 2017-06-27 | RUFFLE JOHN F | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 544,349 | — | ↗ |
| 2017-06-27 | Ozyurek Saim Mert | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 3.90 | 7.8K | 2,000 | — | ↗ |
| 2017-06-27 | Larson David | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 58,664 | — | ↗ |
| 2017-06-27 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock, No Par Value | 500 | 0.00 | — | 11,791 | — | ↗ |
| 2017-05-19 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 3,500 | 3.90 | 13.7K | 76,296 | — | ↗ |
| 2017-05-18 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 3,400 | 3.80 | 12.9K | 79,896 | — | ↗ |
| 2017-03-31 | Tagawa Craig Kenji | Officer | S-Sale | D | Common Stock | 4,200 | 4.32 | 18.1K | 83,296 | — | ↗ |
| 2017-03-31 | Ozyurek Saim Mert | Director | M-Exempt | A | Common Stock | 40,000 | 2.20 | 88.0K | 81,000 | — | ↗ |
| 2017-03-31 | Larson David | Director | M-Exempt | A | Common Stock | 10,000 | 2.20 | 22.0K | 63,257 | — | ↗ |
| 2017-03-30 | BATES ERNEST A | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 4.21 | 21.1K | 645,147 | — | ↗ |
| 2017-03-29 | RUFFLE JOHN F | Director / 10% Owner | M-Exempt | D | Non-Qualified Stock Options (right to buy) | 2,000 | 2.81 | 5.6K | 19,500 | — | ↗ |
| 2017-03-29 | BATES ERNEST A | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 4.24 | 21.2K | 650,147 | — | ↗ |
| 2017-03-27 | TROTMAN STANLEY S JR | Director | G-Gift | D | Common Stock | 87,705 | 4.30 | 377.1K | 239,406 | — | ↗ |
| 2017-01-04 | Tagawa Craig Kenji | Officer | A-Award | A | Common Stock | 58,824 | 0.00 | — | 87,496 | — | ↗ |
| 2017-01-04 | Bates Ernest Robert | Officer | A-Award | A | Common Stock | 36,765 | 0.00 | — | 53,594 | — | ↗ |
| 2017-01-04 | BATES ERNEST A | Director / Officer / 10% Owner | A-Award | A | Common Stock | 66,177 | 0.00 | — | 655,147 | — | ↗ |
| 2017-01-03 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 5,883 | 0.00 | — | 53,209 | — | ↗ |
| 2017-01-03 | Larson David | Director | A-Award | A | Common Stock | 5,883 | 0.00 | — | 53,257 | — | ↗ |
| 2017-01-03 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock | 5,883 | 0.00 | — | 11,291 | — | ↗ |
| 2016-11-15 | Stachowiak Raymond C | Director / 10% Owner | G-Gift | A | Common Stock, No Par Value | 200,000 | 0.00 | — | 600,000 | — | ↗ |
| 2016-07-01 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock | 4,808 | 0.00 | — | 5,408 | — | ↗ |
| 2016-06-22 | Larson David | Director | S-Sale | D | Common Stock | 500 | 2.22 | 1.1K | 49,064 | — | ↗ |
| 2016-06-21 | TROTMAN STANLEY S JR | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 327,111 | — | ↗ |
| 2016-06-21 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 2,000 | 2.25 | 4.5K | 2,000 | — | ↗ |
| 2016-06-21 | RUFFLE JOHN F | Director / 10% Owner | A-Award | A | Stock Options (right to buy) | 2,000 | 2.25 | 4.5K | 2,000 | — | ↗ |
| 2016-06-21 | Ozyurek Saim Mert | Director | A-Award | A | Stock Options (right to buy) | 2,000 | 2.25 | 4.5K | 2,000 | — | ↗ |
| 2016-06-21 | Larson David | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 47,374 | — | ↗ |
| 2016-06-21 | Kelly Daniel G Jr | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 600 | — | ↗ |
| 2016-06-08 | BATES ERNEST A | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100 | 2.09 | 209.00 | 588,970 | — | ↗ |
| 2016-06-07 | BATES ERNEST A | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 97 | 2.09 | 202.73 | 588,470 | — | ↗ |
| 2016-06-06 | BATES ERNEST A | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 310 | 2.03 | 629.30 | 587,970 | — | ↗ |
| 2016-01-04 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 10,582 | 0.00 | — | 48,326 | — | ↗ |
| 2016-01-04 | RUFFLE JOHN F | Director / 10% Owner | A-Award | A | Common Stock | 10,582 | 0.00 | — | 491,349 | — | ↗ |
| 2016-01-04 | Larson David | Director | A-Award | A | Common Stock | 10,582 | 0.00 | — | 46,874 | — | ↗ |
| 2015-08-27 | Larson David | Director | S-Sale | D | Common Stock | 8,600 | 2.07 | 17.8K | 49,564 | — | ↗ |
| 2015-07-07 | Stachowiak Raymond C | Director / 10% Owner | G-Gift | A | Common Stock, No Par Value | 400,000 | 0.00 | — | 400,000 | — | ↗ |
| 2015-06-16 | TROTMAN STANLEY S JR | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 326,611 | — | ↗ |
| 2015-06-16 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock | 500 | 0.00 | — | 37,744 | — | ↗ |
| 2015-06-16 | RUFFLE JOHN F | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 480,767 | — | ↗ |
| 2015-06-16 | Ozyurek Saim Mert | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 40,500 | — | ↗ |
| 2015-06-16 | Larson David | Director | A-Award | A | Common Stock | 500 | 0.00 | — | 36,292 | — | ↗ |
| 2015-05-04 | TROTMAN STANLEY S JR | Director | F-InKind | D | Common Stock | 1,723 | 2.67 | 4.6K | 326,111 | — | ↗ |
| 2015-01-02 | TROTMAN STANLEY S JR | Director | A-Award | A | Deferred RSU | 6,897 | 0.00 | — | 6,897 | — | ↗ |
| 2015-01-02 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Common Stock, No Par Value | 6,897 | 0.00 | — | 37,244 | — | ↗ |
| 2015-01-02 | RUFFLE JOHN F | Director | A-Award | A | Deferred RSU | 6,897 | 0.00 | — | 6,897 | — | ↗ |
| 2015-01-02 | Larson David | Director | A-Award | A | Deferred RSU | 6,897 | 0.00 | — | 6,897 | — | ↗ |
| 2014-12-30 | Tagawa Craig Kenji | Officer | A-Award | A | Stock Options (right to purchase) | 150,000 | 2.82 | 423.0K | 164,500 | — | ↗ |
| 2014-12-30 | TROTMAN STANLEY S JR | Director | A-Award | A | Stock Options (right to purchase) | 7,500 | 2.82 | 21.2K | 25,500 | — | ↗ |
| 2014-12-30 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Stock Options (right to purchase | 7,500 | 2.82 | 21.2K | 7,500 | — | ↗ |
| 2014-12-30 | RUFFLE JOHN F | Director | A-Award | A | Stock Options (right to purchase) | 7,500 | 2.82 | 21.2K | 25,500 | — | ↗ |
| 2014-12-30 | Ozyurek Saim Mert | Director | A-Award | A | Stock Options (right to purchase) | 7,500 | 2.82 | 21.2K | 18,500 | — | ↗ |
| 2014-12-30 | Larson David | Director | A-Award | A | Stock Options (right to purchase) | 7,500 | 2.82 | 21.2K | 18,500 | — | ↗ |
| 2014-12-30 | BATES ERNEST A | Director / Officer / 10% Owner | A-Award | A | Stock Options (right to purchase) | 150,000 | 2.82 | 423.0K | 150,000 | — | ↗ |
| 2014-12-30 | AMERICAN SHARED HOSPITAL SERVICES | Officer | A-Award | A | Stock Options (Right to Purchase) | 112,500 | 2.82 | 317.3K | 112,500 | — | ↗ |
| 2014-12-23 | BATES ERNEST A | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 7,200 | 2.52 | 18.1K | 587,470 | — | ↗ |
| 2014-10-22 | Stachowiak Raymond C | Director / 10% Owner | A-Award | A | Warrants (right to purchase) | 100,000 | 2.20 | 220.0K | 100,000 | — | ↗ |
| 2014-10-22 | RUFFLE JOHN F | Director | A-Award | A | Warrants (right to purchase) | 50,000 | 2.20 | 110.0K | 50,000 | — | ↗ |
| 2014-10-22 | Ozyurek Saim Mert | Director | A-Award | A | Warrants (right to purchase) | 40,000 | 2.20 | 88.0K | 40,000 | — | ↗ |
| 2014-10-22 | Larson David | Director | A-Award | A | Warrants (right to purchase) | 10,000 | 2.20 | 22.0K | 10,000 | — | ↗ |
| 2014-08-22 | BATES ERNEST A | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 20,000 | 2.40 | 48.0K | 594,670 | — | ↗ |
| 2014-06-12 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 50,000 | 2.43 | 121.5K | 325,834 | — | ↗ |
| 2014-06-12 | Stachowiak Raymond C | Director | P-Purchase | A | COMMON STOCK NO PAR VALUE | 400,000 | 2.43 | 972.0K | 455,000 | — | ↗ |
| 2014-06-12 | RUFFLE JOHN F | Director | P-Purchase | A | COMMON STOCK | 200,000 | 2.43 | 486.0K | 480,267 | — | ↗ |
| 2014-06-10 | TROTMAN STANLEY S JR | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 275,834 | — | ↗ |
| 2014-06-10 | Stachowiak Raymond C | Director | A-Award | A | COMMON STOCK NO PAR VALUE | 500 | 0.00 | — | 30,347 | — | ↗ |
| 2014-06-10 | RUFFLE JOHN F | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 280,267 | — | ↗ |
| 2014-06-10 | Ozyurek Saim Mert | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 40,000 | — | ↗ |
| 2014-06-10 | Larson David | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 35,792 | — | ↗ |
| 2014-01-02 | Stachowiak Raymond C | Director | A-Award | A | COMMON STOCK NO PAR VALUE | 7,576 | 0.00 | — | 29,847 | — | ↗ |
| 2013-09-10 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 8,000 | 2.68 | 21.4K | 55,000 | — | ↗ |
| 2013-09-04 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 5,000 | 2.70 | 13.5K | 47,000 | — | ↗ |
| 2013-06-20 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 5,000 | 2.25 | 11.2K | 37,000 | — | ↗ |
| 2013-06-11 | TROTMAN STANLEY S JR | Director | A-Award | A | STOCK OPTION (RIGHT TO BUY) | 2,000 | 2.16 | 4.3K | 25,000 | — | ↗ |
| 2013-06-11 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 500 | 2.16 | 1.1K | 64,271 | — | ↗ |
| 2013-05-29 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 5,000 | 1.90 | 9.5K | 32,000 | — | ↗ |
| 2013-05-16 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 9 | 1.85 | 16.65 | 249,920 | — | ↗ |
| 2013-05-15 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 50,000 | 1.75 | 87.4K | 245,487 | — | ↗ |
| 2013-05-14 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 200 | 1.61 | 322.00 | 195,487 | — | ↗ |
| 2013-01-02 | TROTMAN STANLEY S JR | Director | A-Award | A | COMMON STOCK | 7,143 | 2.80 | 20.0K | 267,258 | — | ↗ |
| 2013-01-02 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 7,143 | 2.80 | 20.0K | 27,216 | — | ↗ |
| 2012-12-21 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 550 | 0.00 | — | 631,070 | — | ↗ |
| 2012-06-28 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | I-Discretionary | A | COMMON STOCK | 5,174 | 3.13 | 16.2K | 5,174 | — | ↗ |
| 2012-06-22 | AMERICAN SHARED HOSPITAL SERVICES | Officer | I-Discretionary | A | COMMON STOCK | 1,990 | 3.04 | 6.0K | 10,175 | — | ↗ |
| 2012-06-14 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 35,000 | 2.85 | 99.8K | 39,000 | — | ↗ |
| 2012-06-07 | Stachowiak Raymond C | Director | A-Award | A | OPTION TO ACQUIRE | 2,000 | 3.05 | 6.1K | 11,000 | — | ↗ |
| 2012-06-07 | RUFFLE JOHN F | Director | A-Award | A | COMMON STOCK | 500 | 3.05 | 1.5K | 249,911 | — | ↗ |
| 2012-06-07 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 500 | 3.05 | 1.5K | 4,000 | — | ↗ |
| 2012-05-30 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 2,500 | 3.05 | 7.6K | 28,672 | — | ↗ |
| 2012-04-04 | AMERICAN SHARED HOSPITAL SERVICES | Director | P-Purchase | A | COMMON STOCK | 3,000 | 3.27 | 9.8K | 3,500 | — | ↗ |
| 2012-01-03 | TROTMAN STANLEY S JR | Director | A-Award | A | COMMON STOCK | 7,634 | 2.62 | 20.0K | 260,115 | — | ↗ |
| 2012-01-03 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 7,634 | 2.62 | 20.0K | 56,628 | — | ↗ |
| 2011-12-29 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 10,000 | 2.62 | 26.2K | 631,070 | — | ↗ |
| 2011-12-28 | AMERICAN SHARED HOSPITAL SERVICES | Officer | G-Gift | D | COMMON STOCK | 1,150 | 2.71 | 3.1K | 31,172 | — | ↗ |
| 2011-07-12 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 3,100 | 3.22 | 10.0K | 641,070 | — | ↗ |
| 2011-06-20 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 5,000 | 3.00 | 15.0K | 32,322 | — | ↗ |
| 2011-06-09 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | STOCK OPTION (RIGHT TO BUY) | 2,000 | 3.15 | 6.3K | 21,000 | — | ↗ |
| 2011-04-29 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 1,000 | 3.41 | 3.4K | 694,170 | — | ↗ |
| 2011-04-15 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 24,000 | 3.12 | 74.9K | 695,170 | — | ↗ |
| 2011-04-06 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 10,000 | 3.12 | 31.2K | 26,832 | — | ↗ |
| 2011-03-11 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 6,550 | 3.57 | 23.4K | 725,170 | — | ↗ |
| 2011-02-17 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 3,150 | 3.25 | 10.2K | 731,720 | — | ↗ |
| 2011-01-03 | TROTMAN STANLEY S JR | Director | A-Award | A | COMMON STOCK | 6,994 | 2.86 | 20.0K | 252,481 | — | ↗ |
| 2011-01-03 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 6,994 | 2.86 | 20.0K | 256,914 | — | ↗ |
| 2010-12-23 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 13,500 | 2.85 | 38.5K | 734,870 | — | ↗ |
| 2010-09-10 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 10,000 | 2.80 | 28.0K | 748,370 | — | ↗ |
| 2010-08-23 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 400 | 2.95 | 1.2K | 36,832 | — | ↗ |
| 2010-06-14 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | G-Gift | D | COMMON STOCK | 25,000 | 2.88 | 72.0K | 758,370 | — | ↗ |
| 2010-06-11 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 1,900 | 2.78 | 5.3K | 37,352 | — | ↗ |
| 2010-06-08 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 480 | 2.80 | 1.3K | 39,252 | — | ↗ |
| 2010-06-02 | Stachowiak Raymond C | Director | A-Award | A | OPTION TO ACQUIRE | 2,000 | 2.81 | 5.6K | 7,000 | — | ↗ |
| 2010-06-02 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | STOCK OPTION (RIGHT TO BUY) | 2,000 | 2.81 | 5.6K | 7,000 | — | ↗ |
| 2010-05-28 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 2,500 | 2.75 | 6.9K | 39,732 | — | ↗ |
| 2010-04-13 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | D-Return | D | COMMON STOCK | 16,000 | 2.75 | 44.0K | 783,370 | — | ↗ |
| 2009-11-20 | AMERICAN SHARED HOSPITAL SERVICES | Officer | G-Gift | D | COMMON STOCK | 1,400 | 3.10 | 4.3K | 42,232 | — | ↗ |
| 2009-09-10 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 25,500 | — | ↗ |
| 2009-08-28 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 10,000 | 2.65 | 26.5K | 43,632 | — | ↗ |
| 2009-08-20 | AMERICAN SHARED HOSPITAL SERVICES | Officer | S-Sale | D | COMMON STOCK | 10,000 | 2.39 | 23.9K | 53,632 | — | ↗ |
| 2009-05-28 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 168,787 | — | ↗ |
| 2008-11-28 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 200 | 1.25 | 250.00 | 168,287 | — | ↗ |
| 2008-11-26 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 4,075 | 1.25 | 5.1K | 168,087 | — | ↗ |
| 2008-11-25 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 3,865 | 1.25 | 4.8K | 164,012 | — | ↗ |
| 2008-11-24 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 7,025 | 1.25 | 8.8K | 160,147 | — | ↗ |
| 2008-11-19 | TROTMAN STANLEY S JR | Director | P-Purchase | A | COMMON STOCK | 8,860 | 1.40 | 12.4K | 153,122 | — | ↗ |
| 2008-06-20 | AMERICAN SHARED HOSPITAL SERVICES | Director | A-Award | A | COMMON STOCK | 500 | 0.00 | — | 144,262 | — | ↗ |
| 2008-03-07 | AMERICAN SHARED HOSPITAL SERVICES | Director / Officer / 10% Owner | A-Award | A | STOCK OPTION (RIGHT TO BUY) | 50,000 | 2.96 | 148.0K | 200,000 | — | ↗ |
| 2007-12-06 | AMERICAN SHARED HOSPITAL SERVICES | Officer | A-Award | A | STOCK OPTION (RIGHT TO BUY) | 100,000 | 2.76 | 276.0K | 134,500 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-20.3K
Shares Outstanding
6.60M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Raymond C. Stachowiak, Executive Chairman | 252.3K | — | 264.0K | — | — | 10.1K | 526.4K | 50.15% | ↗ |
| 2 | 2025 | Gary Delanois, Chief Executive Officer | 400.4K | — | 53.1K | — | — | — | 453.5K | 11.71% | ↗ |
| 3 | 2025 | R. Scott Frech, Chief Financial Officer | 281.6K | — | 25.8K | — | — | 11.0K | 318.4K | 8.11% | ↗ |
| 4 | 2024 | Raymond C. Stachowiak, Executive Chairman | 275.0K | — | 316.8K | — | — | 11.5K | 603.3K | 52.51% | ↗ |
| 5 | 2024 | Craig K. Tagawa, President | 260.5K | — | 19.9K | — | 172.6K | 13.0K | 466.0K | 4.27% | ↗ |
| 6 | 2024 | Gary Delanois Chief Executive Officer | 56.3K | — | 376.8K | — | 30.0K | 110.00 | 463.2K | 81.35% | ↗ |
| 7 | 2024 | Gary Delanois, Chief Executive Officer | 56.3K | — | 376.8K | — | 30.0K | 110.00 | 463.2K | 81.35% | ↗ |
| 8 | 2024 | R. Scott Frech, Chief Financial Officer | 7.4K | — | 161.0K | — | — | — | 168.4K | 95.60% | ↗ |
| 9 | 2023 | Raymond C. Stachowiak, Executive Chairman | 275.0K | — | 351.6K | — | — | — | 626.6K | 56.11% | ↗ |
| 10 | 2023 | Peter M. Gaccione, Chief Executive Officer | 315.4K | — | 32.5K | 81.3K | 30.1K | 13.2K | 472.5K | 24.09% | ↗ |
| 11 | 2023 | Craig K. Tagawa, President | 258.5K | — | 15.0K | — | 30.1K | 13.9K | 317.5K | 4.72% | ↗ |
| 12 | 2022 | Raymond C. Stachowiak, Executive Chairman | 272.0K | — | 288.0K | — | — | — | 560.0K | 51.43% | ↗ |
| 13 | 2022 | Raymond C. Stachowiak, Chief Executive Officer | 272.0K | — | 288.0K | — | — | — | 560.0K | 51.43% | ↗ |
| 14 | 2022 | Craig K. Tagawa, President, Chief Financial Officer | 300.0K | — | 37.5K | — | 100.7K | 12.9K | 451.1K | 8.31% | ↗ |
| 15 | 2022 | Craig K. Tagawa, President | 300.0K | — | 37.5K | — | 100.7K | 12.9K | 451.1K | 8.31% | ↗ |
| 16 | 2022 | Ernest R. Bates, Vice President, International Sales and Business Development | 193.0K | — | 37.5K | — | 87.8K | 9.4K | 327.7K | 11.44% | ↗ |
| 17 | 2022 | Peter M. Gaccione, Chief Executive Officer | 77.3K | — | — | 74.7K | 40.0K | — | 192.0K | 38.92% | ↗ |
| 18 | 2022 | Peter M. Gaccione, Chief Operating Officer | 77.3K | — | — | 74.7K | 40.0K | — | 192.0K | 38.92% | ↗ |
| 19 | 2021 | Raymond C. Stachowiak, Chief Executive Officer | 200.0K | — | 329.4K | — | — | — | 529.4K | 62.22% | ↗ |
| 20 | 2021 | Craig K. Tagawa, President, Chief Financial Officer | 292.5K | — | 37.5K | — | 38.8K | 12.9K | 381.7K | 9.82% | ↗ |
| 21 | 2021 | Craig K. Tagawa, President, Chief Operating Officer and Chief Financial Officer | 292.5K | — | 12.9K | — | 38.8K | 12.9K | 357.2K | 3.62% | ↗ |
| 22 | 2021 | Ernest R. Bates, Vice President, International Sales and Business Development | 225.0K | — | 37.5K | — | 5.6K | 10.0K | 278.1K | 13.49% | ↗ |
| 23 | 2021 | Ernest R. Bates, Senior Vice President of Sales and Business Development and International Operations | 225.0K | — | 1.9K | — | 5.6K | 9.6K | 242.1K | 0.77% | ↗ |
| 24 | 2020 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | — | — | 18.1K | 343.1K | 0.00% | ↗ |
| 25 | 2020 | Craig K. Tagawa, President, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | — | — | 18.1K | 343.1K | 0.00% | ↗ |
| 26 | 2020 | Ernest R. Bates, Senior Vice President of Sales and Business Development and International Operations | 250.0K | — | 21.0K | — | — | 16.6K | 287.6K | 7.30% | ↗ |
| 27 | 2020 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | 21.0K | — | — | 16.6K | 287.6K | 7.30% | ↗ |
| 28 | 2020 | Raymond C. Stachowiak, Chief Executive Officer | 100.0K | — | 179.0K | — | — | 5.8K | 284.5K | 62.92% | ↗ |
| 29 | 2020 | Ernest A. Bates, M.D., Former Chief Executive Officer and Executive Chairman | 244.8K | — | — | — | — | 7.9K | 252.6K | 0.00% | ↗ |
| 30 | 2019 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | — | — | — | 17.5K | 451.8K | 0.00% | ↗ |
| 31 | 2019 | Ernest A. Bates, M.D., Former Chief Executive Officer and Executive Chairman | 434.3K | — | — | — | — | 17.5K | 451.8K | 0.00% | ↗ |
| 32 | 2019 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | — | — | 23.1K | 348.1K | 0.00% | ↗ |
| 33 | 2019 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 20.0K | 270.0K | 0.00% | ↗ |
| 34 | 2018 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | — | — | — | 17.6K | 451.9K | 0.00% | ↗ |
| 35 | 2018 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | — | — | 15.1K | 340.1K | 0.00% | ↗ |
| 36 | 2018 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 18.9K | 268.9K | 0.00% | ↗ |
| 37 | 2017 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | 44.3K | — | — | 20.9K | 499.5K | 8.88% | ↗ |
| 38 | 2017 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 325.0K | — | 39.4K | — | — | 15.6K | 380.0K | 10.37% | ↗ |
| 39 | 2017 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | 24.6K | — | — | 18.9K | 293.5K | 8.39% | ↗ |
| 40 | 2016 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | — | — | — | 21.4K | 455.7K | 0.00% | ↗ |
| 41 | 2016 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | 30.0K | — | — | — | 14.6K | 344.6K | 0.00% | ↗ |
| 42 | 2016 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 18.9K | 268.9K | 0.00% | ↗ |
| 43 | 2015 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | — | — | — | 22.8K | 457.1K | 0.00% | ↗ |
| 44 | 2015 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | — | — | — | — | 16.6K | 316.6K | 0.00% | ↗ |
| 45 | 2015 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 19.1K | 269.1K | 0.00% | ↗ |
| 46 | 2014 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 434.3K | — | — | 174.0K | — | 32.0K | 640.3K | 27.17% | ↗ |
| 47 | 2014 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | — | — | 189.0K | — | 12.5K | 501.5K | 37.69% | ↗ |
| 48 | 2014 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | 141.8K | — | 17.0K | 408.7K | 34.68% | ↗ |
| 49 | 2013 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 447.9K | — | — | — | — | 29.4K | 477.2K | 0.00% | ↗ |
| 50 | 2013 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | — | — | — | — | 15.6K | 315.6K | 0.00% | ↗ |
| 51 | 2013 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 16.8K | 266.8K | 0.00% | ↗ |
| 52 | 2012 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 30.1K | 505.1K | 0.00% | ↗ |
| 53 | 2012 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 351.0K | — | — | — | — | 11.1K | 362.1K | 0.00% | ↗ |
| 54 | 2012 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 16.8K | 266.8K | 0.00% | ↗ |
| 55 | 2011 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 32.6K | 507.6K | 0.00% | ↗ |
| 56 | 2011 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 400.0K | — | — | — | — | 11.1K | 411.1K | 0.00% | ↗ |
| 57 | 2011 | Ernest R. Bates, Vice President of Sales and Business Development | 370.0K | — | — | — | — | 16.6K | 386.6K | 0.00% | ↗ |
| 58 | 2010 | Ernest A. Bates, M.D., Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 34.5K | 509.5K | 0.00% | ↗ |
| 59 | 2010 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 34.5K | 509.5K | 0.00% | ↗ |
| 60 | 2010 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 325.0K | — | — | — | — | 11.1K | 336.1K | 0.00% | ↗ |
| 61 | 2010 | Ernest R. Bates, Vice President of Sales and Business Development | 275.0K | — | — | — | — | 11.1K | 291.6K | 0.00% | ↗ |
| 62 | 2009 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 33.1K | 508.1K | 0.00% | ↗ |
| 63 | 2009 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 475.0K | — | — | — | — | 33.1K | 508.1K | 0.00% | ↗ |
| 64 | 2009 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | — | — | — | — | 10.7K | 310.7K | 0.00% | ↗ |
| 65 | 2009 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | — | — | — | — | 10.7K | 310.7K | 0.00% | ↗ |
| 66 | 2009 | Ernest R. Bates, Vice President of Business Development | 250.0K | — | — | — | — | 15.6K | 265.6K | 0.00% | ↗ |
| 67 | 2009 | Ernest R. Bates, Vice President of Sales and Business Development | 250.0K | — | — | — | — | 15.6K | 265.6K | 0.00% | ↗ |
| 68 | 2008 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 475.0K | 47.5K | — | — | — | 29.3K | 592.3K | 0.00% | ↗ |
| 69 | 2008 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 300.0K | 30.0K | — | — | — | 16.3K | 346.3K | 0.00% | ↗ |
| 70 | 2008 | Ernest R. Bates, Vice President of Business Development | 250.0K | 25.0K | — | — | — | 15.0K | 290.0K | 0.00% | ↗ |
| 71 | 2008 | Craig K. Tagawa, Chief Operating Officer and | — | — | — | — | — | — | — | — | ↗ |
| 72 | 2008 | Ernest A. Bates, M.D. Chairman of the Board and | — | — | — | — | — | — | — | — | ↗ |
| 73 | 2008 | Ernest R. Bates, Vice President of Business | — | — | — | — | — | — | — | — | ↗ |
| 74 | 2007 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 475.0K | 47.5K | — | — | — | 29.0K | 551.5K | 0.00% | ↗ |
| 75 | 2007 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 299.2K | 30.0K | — | — | — | 15.8K | 349.4K | 0.00% | ↗ |
| 76 | 2007 | Ernest R. Bates, Vice President of Business Development | 240.4K | 25.0K | — | — | — | 14.9K | 302.0K | 0.00% | ↗ |
| 77 | 2007 | Craig K. Tagawa, Chief Operating Officer and | — | — | — | — | — | — | — | — | ↗ |
| 78 | 2007 | Ernest R. Bates, Vice President of Business | — | — | — | — | — | — | — | — | ↗ |
| 79 | 2007 | Ernest A. Bates, M.D. Chairman of the Board and | — | — | — | — | — | — | — | — | ↗ |
| 80 | 2006 | Ernest A. Bates, M.D. Chairman of the Board and Chief Executive Officer | 455.8K | 165.0K | — | — | — | 32.5K | 653.3K | 0.00% | ↗ |
| 81 | 2006 | Craig K. Tagawa, Chief Operating Officer and Chief Financial Officer | 259.8K | 100.0K | — | — | — | 16.8K | 381.0K | 0.00% | ↗ |
| 82 | 2006 | Ernest R. Bates, Vice President of Business Development | — | — | — | — | — | — | — | — | ↗ |
| 83 | 2005 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.8K | — | — | — | — | — | 432.8K | 0.00% | ↗ |
| 84 | 2005 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 259.2K | 50.0K | — | — | — | — | 309.2K | 0.00% | ↗ |
| 85 | 2004 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.8K | — | — | — | — | — | 432.8K | 0.00% | ↗ |
| 86 | 2004 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 260.7K | 50.0K | — | — | — | — | 310.7K | 0.00% | ↗ |
| 87 | 2003 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.4K | — | — | — | — | — | 432.4K | 0.00% | ↗ |
| 88 | 2003 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 250.9K | 100.0K | — | — | — | — | 350.9K | 0.00% | ↗ |
| 89 | 2002 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.6K | — | — | — | — | — | 432.6K | 0.00% | ↗ |
| 90 | 2002 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.6K | — | — | — | — | — | 432.6K | 0.00% | ↗ |
| 91 | 2002 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 274.5K | — | — | — | — | — | 274.5K | 0.00% | ↗ |
| 92 | 2002 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 274.5K | — | — | — | — | — | 274.5K | 0.00% | ↗ |
| 93 | 2001 | Ernest A. Bates, M.D. Chairman of the Board, Chief Executive Officer | 432.3K | 55.8K | — | — | — | — | 488.0K | 0.00% | ↗ |
| 94 | 2001 | Craig K. Tagawa Chief Operating Officer and Chief Financial Officer | 305.8K | 30.7K | — | — | — | — | 336.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Craig K. Tagawa | Interim Chief Executive Officer | 446.1K | male |
| Frech Raymond Scott | Chief Financial Officer | 292.6K | — |
| Raymond Scott Frech | Chief Financial Officer | 292.6K | male |
| Gary Delanois | Chief Executive Officer | 291.7K | male |
| Ernest R. Bates | Vice President of International Sales & Marketing | 290.2K | male |
| Raymond C. Stachowiak | Executive Chairman | 286.5K | male |
| Alexis N. Wallace | Chief Accounting Officer & Corporate Secretary | — | female |
| Greg Mercurio | Senior Vice President of Radiation Oncology | — | male |
| Ranjit Pradhan | Senior Vice President of Sales & Marketing | — | male |
ESG Rating
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AMS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
